Lisata Therapeutics, Inc.LSTANASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank57
5Y CAGR-22.5%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

5Y CAGR
-22.5%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202520.42%
20246.98%
202375.36%
2022-40.54%
20215.82%
202072.91%
2019-16.66%
2018-165.13%
2017151.37%
201670.09%